Ticker: CBPO, Company: China Biologic Products Holdings, Inc., Type: 6-K, Date: 2020-08-17
Original SEC Filing: Click here

---

Webplus: CBPO/20200817/6-K_1/2_EX-99.1/000.htm SEC Original: tm2028761d1_ex99-1.htm
China Biologic Reports Financial Results for the Second Quarter of 2020 BEIJING, China – August 17, 2020 – Second Quarter 2020 Financial Highlights · Total sales · Gross profit Gross margin · Income from operations Operating margin · Non-GAAP adjusted income from operations · Net income attributable to the Company Diluted earnings per share · Non-GAAP adjusted net income attributable

---

---

Webplus: CBPO/20200817/6-K_1/3_EX-99.2/000.htm SEC Original: tm2028761d1_ex99-2.htm
China Biologic Second Quarter 2020 Financial Results Second Quarter 2020 Financial Performance Total sales Total sales for biopharmaceutical products decreased by 20.3% in USD terms, or 17.1% in RMB terms, to $97.5 million in the second quarter of 2020 from $122.3 million in the same quarter of 2019, mainly because of decreases in sales of IVIG, albumin, coagulation factor and

---

---

Webplus: CBPO/20200817/6-K_1/1/000.htm SEC Original: tm2028761d1_6k.htm

---

Company Info:

Ticker: CBPO, Company: China Biologic Products Holdings, Inc., Type: 6-K, Date: 2020-08-17CIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING, 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT
BEIJING 100125